Blue Water Life Science Advisors, LP Care Dx, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $114 Million
- Q3 2024
A detailed history of Blue Water Life Science Advisors, LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 604,000 shares of CDNA stock, worth $14.2 Million. This represents 16.58% of its overall portfolio holdings.
Number of Shares
604,000
Previous 510,000
18.43%
Holding current value
$14.2 Million
Previous $7.92 Million
138.08%
% of portfolio
16.58%
Previous 7.7%
Shares
9 transactions
Others Institutions Holding CDNA
# of Institutions
218Shares Held
50.4MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$125 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$107 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$74.2 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$56.8 Million0.45% of portfolio
-
State Street Corp Boston, MA2.04MShares$48 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.26B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...